Establishment of Mouse Teratocarcinomas Stem Cells Line and Screening Genes Responsible for Malignancy

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Liu, Tao ^a   Wang, Ying ^a   Peng, Xinrong ^a   Zhang, Liqing ^b   Cheng, Jingbo ^a   Jin, Huajun ^a   Wu, Mengchao ^a   Qian, Qijun ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARNT GENE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL ISOLATION; CULTURE MEDIUM; DOWN REGULATION; EARLY CANCER; EMBRYONAL CARCINOMA STEM CELL; EPIGENETICS; GATA3 GENE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GRAFT REJECTION; HIGH THROUGHPUT SCREENING; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; ONCOGENE; PHC1 GENE; TDGF1 GENE; TERATOCARCINOMA; TUMOR GENE; UPREGULATION; UTY GENE; WNT SIGNALING PATHWAY;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; EMBRYONAL CARCINOMA STEM CELLS; GENES, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; IMMUNOCOMPROMISED HOST; INJECTIONS; MICE; STEM CELL TRANSPLANTATION;

MUS;

EID: 84865640904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043955     Document Type: Article

References (32)

1. Fawcett DW, (1950) Bilateral ovarian teratomas in a mouse. Cancer Res 10: 705-707.
2. Damjanov I, (1993) Teratocarcinoma: neoplastic lessons about normal embryogenesis. Int J Dev Biol 37: 39-46.
3. Stevens LC, (1970) The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 21: 364-382.
4. Solter D, Skreb N, Damjanov I, (1970) Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature 227: 503-504.
5. Evans MJ, Kaufman MH, (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
6. Martin GR, (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78: 7634-7638.
7. Sell S, (1993) Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ Health Perspect 101 (Suppl 5):: 15-26.
8. Brinster RL, (1974) The effect of cells transferred into the mouse blastocyst on subsequent development. J Exp Med 140: 1049-1056.
9. Papaioannou VE, McBurney MW, Gardner RL, Evans MJ, (1975) Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258: 70-73.
10. Mintz B, Illmensee K, (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 72: 3585-3589.
11. Damjanov I, Solter D, Serman D, (1973) Teratocarcinoma with the capacity for differentiation restricted to neuro-ectodermal tissue. Virchows Arch B Cell Pathol 13: 179-195.
12. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, et al. (2008) The ground state of embryonic stem cell self-renewal. Nature 453: 519-523.
13. Ying QL, Nichols J, Evans EP, Smith AG, (2002) Changing potency by spontaneous fusion. Nature 416: 545-548.
14. Li R, Yu C, Li Y, Lam TW, Yiu SM, et al. (2009) SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25: 1966-1967.
15. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
16. Chambers I, Smith A, (2004) Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23: 7150-7160.
17. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, et al. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444.
18. Peng S, Maihle NJ, Huang Y, (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29: 2153-2159.
19. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, et al. (2008) GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13: 141-152.
20. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R, (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 285: 14042-14051.
21. Semenza GL, (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8: S62-67.
22. Bulic-Jakus F, Ulamec M, Vlahovic M, Sincic N, Katusic A, et al. (2006) Of mice and men: teratomas and teratocarcinomas. Coll Antropol 30: 921-924.
23. Bonner AE, Wang Y, You M, (2004) Gene expression profiling of mouse teratocarcinomas uncovers epigenetic changes associated with the transformation of mouse embryonic stem cells. Neoplasia 6: 490-502.
24. Tanaka SS, Kojima Y, Yamaguchi YL, Nishinakamura R, Tam PP, (2011) Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo. Dev Growth Differ 53: 843-856.
25. Takebe N, Harris PJ, Warren RQ, Ivy SP, (2011) Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 8: 97-106.
26. Espada J, Calvo MB, Diaz-Prado S, Medina V, (2009) Wnt signalling and cancer stem cells. Clin Transl Oncol 11: 411-427.
27. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
28. Lu D, Carson DA, (2011) Inhibition of Wnt signaling and cancer stem cells. Oncotarget 2: 587.
29. de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, et al. (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 10: 648-660.
30. Ben-Yosef T, Eden A, Benvenisty N, (1998) Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2. Mamm Genome 9: 595-597.
31. Zhong Y, Wang Z, Fu B, Pan F, Yachida S, et al. (2011) GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS One 6: e22129.
32. Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, et al. (2010) TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer. Int J Oncol 36: 563-568.